Avadel pharmaceuticals announces appointment of brandi robinson as senior vice president, corporate affairs

Dublin, ireland, march 14, 2022 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a company focused on transforming medicines to transform lives, today announced the appointment of brandi robinson to the newly created position of senior vice president, corporate affairs.
AVDL Ratings Summary
AVDL Quant Ranking